Shahab Asgharzadeh

11PUBLICATIONS
121CO-AUTHORS
Predictive and prognostic markersHaematological tumoursRadiation therapyCancer therapy (excl. chemotherapy and radiation therapy)Computational neuroscience (incl. mathematical neuroscience and theoretical neuroscience)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Oct 27, 2025
Sequential Combination of Unfavorable Histology, Followed by Clinical Stage M, Defines High-Risk Neuroblastoma: A Report from the Children's Oncology Group.

Florette K Hazard, Angus M S Toland, Serena Y Tan

|Jul 14, 2025
Myeloid-targeting immunotherapies overcome inhibitory barriers in immune-evasive neuroblastoma.

Marie Ménard, Hiroyuki Yoda, Nicole Nasholm

|Jun 23, 2025
Phase I Study of 131I-Metaiodobenzylguanidine With Dinutuximab ± Vorinostat for Patients With Relapsed or Refractory Neuroblastoma: A New Approaches to Neuroblastoma Therapy Trial.

Thomas Cash, Araz Marachelian, Steven G DuBois

|Dec 03, 2024
CD33-CD123 IF-THEN Gating Reduces Toxicity while Enhancing the Specificity and Memory Phenotype of AML-Targeting CAR-T Cells.

Samy Jambon, Jianping Sun, Shawn Barman

|Jul 31, 2024
Identification and Characterization of Chemotherapy-Resistant High-Risk Neuroblastoma Persister Cells.

Liron D Grossmann, Chia-Hui Chen, Yasin Uzun

|Feb 23, 2023
KIR/KIR-ligand genotypes and clinical outcomes following chemoimmunotherapy in patients with relapsed or refractory neuroblastoma: a report from the Children's Oncology Group.

Amy K Erbe, Mitch B Diccianni, Rajen Mody

Pageof 2

Frequent Collaborators

5 joint publications

John M Maris

4 joint publications

Julie R Park

3 joint publications

Rochelle Bagatell

3 joint publications

Michael D Hogarty